Astrana Health, Inc. (ASTH) 의 후행 P/E는 59.8, 선행 P/E 23.7. 후행 이익수익률은 1.67%, 선행 이익수익률 4.22%. PEG 0.14 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $10.80.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 56/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2017 | 23.7 | 0.00 | 3.83 | 1.71 | 1.71% |
| 2018 | 60.3 | -0.90 | 3.62 | 1.26 | 2.72% |
| 2019 | 45.3 | 1.87 | 3.34 | 1.14 | 9.66% |
| 2020 | -28.1 | -0.18 | 2.02 | 1.80 | 7.69% |
| 2021 | 46.7 | 0.92 | 7.19 | 4.16 | 0.97% |
| 2022 | 29.5 | -0.81 | 2.45 | 1.16 | 1.05% |
| 2023 | 29.8 | 0.99 | 2.95 | 1.31 | 3.43% |
| 2024 | 34.8 | -1.16 | 2.11 | 0.74 | 0.27% |
| 2025 | 54.1 | -1.09 | 1.56 | 0.38 | 0.65% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2015 | $-1.79 | $44.05M | $-9.34M | -21.2% |
| 2017 | $0.90 | $357.75M | $25.8M | 7.2% |
| 2018 | $0.29 | $519.91M | $10.84M | 2.1% |
| 2019 | $0.39 | $560.62M | $14.12M | 2.5% |
| 2020 | $-0.63 | $370.25M | $-23.75M | -6.4% |
| 2021 | $1.52 | $773.92M | $68.92M | 8.9% |
| 2022 | $0.99 | $1.14B | $45.17M | 3.9% |
| 2023 | $1.29 | $1.39B | $60.72M | 4.4% |
| 2024 | $0.89 | $2.03B | $43.15M | 2.1% |
| 2025 | $0.46 | $3.18B | $22.49M | 0.7% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $1.23 | $0.03 – $1.76 | $3.99B | $3.97B – $4B | 4 |
| 2027 | $1.88 | $0.80 – $2.96 | $4.38B | $4.03B – $4.74B | 4 |
| 2028 | $2.21 | $2.11 – $2.33 | $4.64B | $4.48B – $4.83B | 1 |
| 2029 | $2.81 | $2.68 – $2.96 | $5.02B | $4.84B – $5.22B | 1 |
| 2030 | $3.40 | $3.24 – $3.58 | $5.41B | $5.22B – $5.63B | 1 |
